$0.298 0.0 0.0%
Last Trade - 08/04/21
| Market Cap | £210k |
| Enterprise Value | £5.03m |
| Revenue | £2.43m |
| Position in Universe | th / 6827 |
| Industry | Market | |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
| Year End 31st Dec | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016E | 2017E | CAGR / Avg | |
|---|---|---|---|---|---|---|---|---|---|---|
| 3.07 | 0.000 | 0.000 | 0.018 | 0.15 | 0.000 | -100.0% | ||||
|
x
|
||||||||||
| Profitability | ||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
| Cashflow | ||||||||||
| Dividends | ||||||||||
| Balance Sheet | ||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing % | |||
| Net Gearing % | |||
| Cash / Assets % |
| Liquidity (ttm) | ||
|---|---|---|
| Curr. Ratio | ||
| Quick Ratio | ||
| Interest Cov. | ||
| Efficiency (ttm) | ||
|---|---|---|
| Asset Turnover | ||
| Recs Turnover | ||
| Stock Turnover | ||
| Latest interim period vs. prior period | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
| 3yr Compound Annual Growth Rate | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
Revenue
Net Income
Normalised EPS
PE Ratio Range
Dividend Yield Range
|
Price Target:
( below Price)
|
31st Dec 2021
|
31st Dec 2022
|
||||
|---|---|---|---|---|---|---|
| Est. Long Term Growth Rate: |
Net Profit () |
EPS () |
DPS () |
Net Profit () |
EPS () |
DPS () |
| Consensus Estimate | ||||||
| 1m Change | ||||||
| 3m Change | ||||||
VeriTeQ Corporation is a medical technology holding company that operates as an online retailer of orthopedic braces and physical therapy and rehabilitation equipment through its subsidiary, Brace Shop, LLC (Brace Shop). Brace Shop operates as an online retailer of orthopedic braces and supports in various categories, such as knee, ankle, back, wrist, shoulder, elbow, foot and neck; physical therapy and rehabilitation equipment, such as hot and cold therapy, electric stimulation, medical tables and ambulatory devices. Brace Shop directly distributes products to a range of customers in various industries and fields, including healthcare professionals, hospitals, physical therapy and rehabilitation clinics, government institutions and school athletic programs. Brace Shop primarily distributes these products to the general public through its Website www.braceshop.com.
| Last Annual | December 31st, 2015 |
| Last Interim | September 30th, 2016 |
| Incorporated | March 7, 2007 |
| Public Since | January 23, 2004 |
| No. of Shareholders: | n/a |
| No. of Employees: | 11 |
| Sector | Technology |
| Industry | Software & IT Services |
| Index | |
| Exchange | Pink Sheets on Nasdaq |
| Shares in Issue | 965,635 |
| Free Float | (0.0%) |
| Eligible for |
×
ISAs
✓
SIPPs
|
| Address | 220 Congress Park Dr Ste 200, DELRAY BEACH, 33445-4605, United States |
| Web | |
| Phone | +1 651 4551621 |
| Auditors | Salberg & Company, P.A. |
As of 08/04/21, shares in Veriteq are trading at $0.298, giving the company a market capitalisation of £210k. This share price information is delayed by 15 minutes.
Shares in Veriteq are currently trading at $0.298 and the price has moved by 1.32k% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Veriteq price has moved by 0.848k% over the past year.
Of the analysts with advisory recommendations for Veriteq, there are there are currently 0 "buy" , 1 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Veriteq is Hold. You can view the full broker recommendation list by unlocking its StockReport.
Veriteq is scheduled to issue upcoming financial results on the following dates:
Veriteq does not currently pay a dividend.
Veriteq does not currently pay a dividend.
Veriteq does not currently pay a dividend.
To buy shares in Veriteq you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
Shares in Veriteq are currently trading at $0.298, giving the company a market capitalisation of £210k.
Here are the trading details for Veriteq:
We were not able to load our ranking data for Veriteq
We were not able to load any forecast data for Veriteq.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Veriteq. Over the past six months, the relative strength of its shares against the market has been 0.152k%. At the current price of $0.298, shares in Veriteq are trading at 0.170k% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Veriteq PE ratio based on its reported earnings over the past 12 months is 0.04. The shares are currently trading at $0.298.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Veriteq's management team is headed by:
Here are the top five shareholders of Veriteq based on the size of their shareholding:
